XML 29 R9.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2016   0 13,036,954      
Beginning balance at Dec. 31, 2016 $ 270,361   $ 218,354 $ 59,386 $ (7,482) $ 103
Exercise of common stock options, includes net settlement of shares (in shares)     166,894      
Exercise of common stock options, includes net settlement of shares 1,615   $ 1,615      
Exercise of common stock warrants (in shares)     12,461      
Exercise of common stock warrants 150   $ 150      
Issuance of restricted stock, net of forfeitures (in shares)     26,718      
Issuance of restricted stock, net of forfeitures 0          
Stock based compensation expense, net of forfeitures 2,802   $ 2,802      
Reclassification of disproportionate tax effect 0     1,202 (1,202)  
Stock issued in conjunction with 401 (k) employer match, net of distributions (in shares)     (5,899)      
Stock issued in conjunction with 401(k) employer match, net of distributions 256   $ 256      
Net income 28,099     28,099    
Earnings attributable to noncontrolling interest (16)     (16)    
Other comprehensive loss 1,898       1,898  
Ending balance (in shares) at Dec. 31, 2017   0 13,237,128      
Ending balance at Dec. 31, 2017 304,653   $ 222,665 88,671 (6,786) 103
Exercise of common stock options, includes net settlement of shares (in shares)     216,400      
Exercise of common stock options, includes net settlement of shares 3,047   $ 3,047      
Issuance of restricted stock, net of forfeitures (in shares)     122,469      
Issuance of restricted stock, net of forfeitures 0          
Stock based compensation expense, net of forfeitures 6,569   $ 6,569      
Stock issued in conjunction with 401 (k) employer match, net of distributions (in shares)     (8,302)      
Stock issued in conjunction with 401(k) employer match, net of distributions 308   $ 308      
Stock issued for acquisition, net of issuance costs (in shares)     (970,390)      
Stock issued for acquisition, net of issuance costs (32,932)   $ (32,932)      
Net income 34,521     34,521    
Earnings attributable to noncontrolling interest (16)     (16)    
Reclassification of issuance costs on preferred stock of consolidated subsidiary noncontrolling interest (10)         (10)
Other comprehensive loss (8,555)       (8,555)  
Ending balance (in shares) at Dec. 31, 2018   0 14,538,085      
Ending balance at Dec. 31, 2018 372,833   $ 264,905 123,176 (15,341) 93
Exercise of common stock options, includes net settlement of shares (in shares)     307,855      
Exercise of common stock options, includes net settlement of shares 5,307   $ 5,307      
Issuance of restricted stock, net of forfeitures (in shares)     3,074      
Issuance of restricted stock, net of forfeitures 0          
Stock based compensation expense, net of forfeitures 5,917   $ 5,917      
Stock issued in conjunction with 401 (k) employer match, net of distributions (in shares)     (997)      
Stock issued in conjunction with 401(k) employer match, net of distributions 0          
Purchase of treasury stock (in shares)     (26,423)      
Purchase of treasury stock (717)   $ (717)      
Cash dividends - Common stock ($0.18 per share) (2,636)     (2,636)    
Net income 14,822     14,822    
Earnings attributable to noncontrolling interest (16)     (16)    
Other comprehensive loss 17,160       17,160  
Ending balance (in shares) at Dec. 31, 2019   0 14,821,594      
Ending balance at Dec. 31, 2019 $ 410,426   $ 275,412 $ 133,102 $ 1,819 $ 93